Atorvastatin tablet formulation
Pro Research Analysisby 
Searched over 200M research papers
Atorvastatin Tablet Formulation: Key Approaches and Considerations
Solid Form Selection and Stability in Atorvastatin Tablets
The choice of solid form is crucial in atorvastatin tablet formulation. Atorvastatin calcium can exist in different solid forms, such as trihydrate and amorphous, each with unique stability and manufacturing considerations. For example, atorvastatin calcium trihydrate (ACT) requires careful monitoring during manufacturing to prevent unwanted phase transitions due to temperature and humidity changes. Studies confirm that ACT Form I can be successfully formulated into tablets using excipients like microcrystalline cellulose, calcium carbonate, lactose monohydrate, croscarmellose sodium, hydroxypropyl cellulose, magnesium stearate, and polysorbate 80, with final products meeting pharmacopeial quality standards for weight variation, hardness, disintegration, dissolution, and assay tests . Amorphous atorvastatin calcium, being highly susceptible to hydrolysis and oxidation, is best processed using dry granulation methods to avoid moisture exposure, resulting in immediate-release tablets with excellent dissolution and stability profiles .
Enhancing Dissolution and Bioavailability: Innovative Formulation Strategies
Atorvastatin is a BCS Class II drug with low solubility and limited bioavailability, making dissolution enhancement a primary goal in tablet formulation. Several strategies have been explored:
- Cocrystal Formation: Atorvastatin calcium cocrystals (ATC-Cs) with coformers like glucosamine and nicotinamide, prepared by solvent drop grinding or evaporation, can be directly compressed into tablets. These formulations show improved dissolution rates and stability under standard storage, though partial dissociation may occur at elevated temperatures over time .
- Porous Tablets via Sublimation: Creating porous atorvastatin trihydrate calcium tablets using sublimation and direct compression significantly increases drug release compared to marketed products, with over 85% release in 25 minutes and good stability over 90 days .
- Liquisolid Systems: Formulating atorvastatin calcium as a liquisolid tablet using PEG 400 as a solvent and carriers like Avicel PH 101/102 or Neusilin US2 enhances dissolution rates compared to conventional tablets, with no drug-excipient incompatibility detected .
- Nanotechnology: Nanocrystal and nanoparticle formulations, such as atorvastatin-chitosan nanoparticles or nanocrystals with Soluplus, greatly improve solubility, dissolution, and potentially bioavailability. Mouth-dissolving tablets with nanoparticles show rapid and complete drug release, bypassing first-pass metabolism and enhancing absorption 79.
Immediate-Release and Specialized Tablet Designs
Immediate-release atorvastatin tablets can be achieved by incorporating phospholipid solid dispersions (PSD) with suitable adsorbents and superdisintegrants. For instance, tablets containing phosphatidylcholine and magnesium aluminum silicate, combined with croscarmellose sodium, achieve over 90% drug release within 15 minutes and rapid disintegration .
Bilayered tablets with bioenhancers like piperine have also been developed to increase atorvastatin bioavailability. Formulations using superdisintegrants and piperine show improved in vitro release compared to standard tablets .
Chronotherapeutic and Pulsatile Delivery Systems
Press-coated, pulsatile-release atorvastatin tablets are designed to align drug release with the circadian rhythm of cholesterol synthesis, releasing the drug after a predetermined lag time (e.g., 4 hours post-administration at bedtime). These systems use outer coatings of gums like xanthan and guar gum and are evaluated for compatibility, stability, and targeted release profiles .
Conclusion
Atorvastatin tablet formulation has advanced through various innovative approaches to address challenges of solubility, stability, and bioavailability. Techniques such as cocrystal formation, porous tablet design, liquisolid systems, nanotechnology, and specialized delivery systems have all demonstrated improved dissolution rates and product quality. Careful selection of solid form, excipients, and manufacturing methods is essential to ensure stable, effective, and high-quality atorvastatin tablets suitable for clinical use 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic